Page 25 - காரணிகள் அந்த இருக்கலாம் செயல்விளைவு உண்டுபண்ணு எதிர்கால News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from காரணிகள் அந்த இருக்கலாம் செயல்விளைவு உண்டுபண்ணு எதிர்கால. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In காரணிகள் அந்த இருக்கலாம் செயல்விளைவு உண்டுபண்ணு எதிர்கால Today - Breaking & Trending Today

Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®

Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Sylke Maas , Albert Bourla , Andrew Widger , Chuck Triano , Ugur Sahin , Fosun Pharma , European Commission , Bayer Animal Health , Exchange Commission , Pfizer Inc , European Union , Roche Group , European Medicines Agency , Chief Executive Officer , Marketing Authorizations Holder , Product Characteristics , Package Leaflet , Breakthroughs That Change Patient , Disclosure Notice , Biologics License Application , Annual Report , Looking Information , Factors That May Affect Future , New Technologies ,

Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine

BioNTech SE (Nasdaq: BNTX) today announced that the U.S. government has exercised its option for an additional 100 million doses of the Pfizer-BioNTech COVID-19 vaccine. This brings the total number of doses to be supplied by the companies to the U.S. government to 300 million.
“We support the new administration s plan to vaccinate as many people as quickly as possible because there is an urgent need to help protect people from this virus, here in the U.S. and across the globe,” said
Albert Bourla, Chairman and Chief Executive Officer, Pfizer. We are pleased to work with the administration to provide these additional vaccines, so that more Americans receive their first and second doses as soon as possible. ....

United States , United Kingdom , Sylke Maas , Albert Bourla , Chuck Triano , Amy Rose , Ugur Sahin , Fosun Pharma , Centers For Disease , Drug Administration , Bayer Animal Health , Exchange Commission , Pfizer Inc , European Union , Roche Group , Vaccine Administration Under Emergency Use Authorization , Chief Executive Officer , Marketing Authorization Holder , Emergency Use Authorization , Coronavirus Disease , Fact Sheet , Healthcare Providers Administering Vaccine , Vaccination Providers , Disease Control , Adverse Events , Mandatory Requirements ,

Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine

Investegate announcements from BioNTech SE, Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine ....

United States , United Kingdom , Sylke Maas , Albert Bourla , Chuck Triano , Amy Rose , Ugur Sahin , Fosun Pharma , Centers For Disease , Drug Administration , Bayer Animal Health , Exchange Commission , Pfizer Inc , European Union , Roche Group , Vaccine Administration Under Emergency Use Authorization , Additional Doses , Chief Executive Officer , Marketing Authorization Holder , Emergency Use Authorization , Coronavirus Disease , Fact Sheet , Healthcare Providers Administering Vaccine , Vaccination Providers , Disease Control , Adverse Events ,

BioNTech SE: Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine

U.S. government exercises option to bring total supply to 300 million doses, enabling vaccinations for 150 million people NEW YORK and MAINZ, GERMANY, February 12, 2021 - Pfizer Inc.(Nasdaq: BNTX) ....

United States , United Kingdom , Sylke Maas , Albert Bourla , Chuck Triano , Amy Rose , Ugur Sahin , Fosun Pharma , Centers For Disease , Pfizer Inc Nasdaq , Drug Administration , Bayer Animal Health , Exchange Commission , European Union , Roche Group , Vaccine Administration Under Emergency Use Authorization , Chief Executive Officer , Marketing Authorization Holder , Emergency Use Authorization , Disease Control , Adverse Events , Fact Sheet , Mandatory Requirements , Administration Under Emergency Use , Emergency Use , Breakthroughs That Change Patient ,

Lightbridge Receives Notice of Allowance on Key Patent from the Korean Intellectual Property Office

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Lightbridge Receives Notice of Allowance on Key Patent from the Korean Intellectual Property Office
Lightbridge CorporationFebruary 8, 2021 GMT
RESTON, Va., Feb. 08, 2021 (GLOBE NEWSWIRE) Lightbridge Corporation (NASDAQ: LTBR), an advanced nuclear fuel technology company, today announced that it has received a Notice of Allowance from the Korean Intellectual Property Office for a new patent covering a broad scope of innovations: (1) an alternative metallic fuel rod design whereby an axial centerline of the fuel rod is offset from an axial center of mass; (2) a fuel assembly incorporating such fuel rods; (3) a metallic fuel assembly design with metallic fuel rods arranged in a mixed grid pattern; (4) various embodiments of a corner structure attached to the shroud. ....

United States , Seth Grae , Matthew Abenante , Exchange Commission , Korean Intellectual Property Office , Lightbridge Corporation , Chief Executive Officer , Lightbridge Fuel , Private Securities Litigation Reform Act , Annual Report , Looking Information , Factors That May Affect Future , Relations Contact , Investor Relations , Energy And The Environment , Electric Utilities , Environment And Nature , Covid 19 Pandemic , Lung Disease , North America , Coronavirus Pandemic , Energy Industry , Diseases And Conditions , Infectious Diseases , Intellectual Property , Globe Newswire ,